Dr. Posner has worked as a consultant for several years with the largest multi-national and small national pharmaceutical and biotech companies on a wide variety of projects. These include contributing to the strategy of drug development and portfolio analysis, devising and executing early development plans for new molecular entities and designing and overseeing conduct of first in human, pharmacokinetic and proof of principle phase I and II studies. He has also authored numerous clinical overviews and supporting documents for product license applications in the United States, Europe and Australia and advised companies on regulatory strategy at various stages of drug development.From 1996 to 1999, he served as medical director and subsequently chief executive officer of BIOS (consultancy & contract research). Previously he was international director of clinical study units, at GlaxoWellcome and head of clinical pharmacology at The Wellcome Foundation for 10 years. Dr. Posner is a board certified physician in internal medicine, a Fellow of the Royal College of Physicians (FRCP) and of the Faculty of Pharmaceutical Medicine and is an executive editor of the British Journal of Clinical Pharmacology.